Based in Tokyo, our latest stock recommendation is one of the world's leading sellers of automobiles, with a well-deserved reputation for quality and reliability, suggests Mark Skousen in High-Income Alert.
Sales for Honda Motor (HMC) exceeded $130 billion during the last 12 months. Under the Honda and Acura brands, the firm sells autos, trucks, motorcycles, and all-terrain vehicles.
However, many consumers put off purchasing a new vehicle during the recent worldwide economic slowdown. That situation is about to change.
The age of the average vehicle on US roads recently hit an all-time record: 11.4 years. There is enormous pent-up demand for new cars and trucks. And we are beginning to see that demand show up in the Honda sales numbers.
In the most recent quarter, sales jumped 16.3%. And they are likely to climb sharply higher in the months ahead. Honda will earn approximately $2.50 a share in 2013. But I estimate net income will climb 40% in the year ahead.
Hot Bank Stocks To Invest In Right Now: Cermaq ASA (CEQ)
Cermaq ASA is a Norway-based company active in the aquaculture industry. It is engaged in the farming of salmon and trout. The Company, along with its subsidiaries, operates in one business segment, namely Aquaculture, which consists of two divisions: Fish Feed production, which involves the production and sale of fish feed, and Fish Farming, which involves the breeding and on-growing, as well as the slaughtering, processing, sale and distribution of salmon and trout. The Company�� other activities consist of operations carried out through its subsidiary, Norgrain AS, the associated company, Denofa AS and the parent company. The Company operates through its subsidiaries, including Statkorn Aqua AS and Mainstream Norway AS, among others. In October 2013, the Company sold its second business segment, EWOS Group, to Altor Fund III and Bain Capital. Advisors' Opinion:- [By Chuck Carnevale]
Additional strengths supporting Aflac�� business model can be found by reviewing their common equity or book value (ceq), the lime green line on the following graph, in comparison to their current market value (mkval), the aqua colored more jagged line on the graph. Aflac�� book value has increased steadily except for a minor pause during the Great Recession of 2008. In contrast, their market value has been much more cyclical and erratic. I believe this additionally reflects current undervaluation of Aflac�� shares. This further supports my contention that Aflac is a great business that is currently on sale.
10 Best Quality Stocks For 2014: Super Micro Computer Inc.(SMCI)
Super Micro Computer, Inc., together with its subsidiaries, develops and provides high performance server solutions based on modular and open-standard architecture. The company offers a range of rackmount, workstation, storage, graphic processing unit, and blade server systems, as well as subsystems and accessories used by distributors, original equipment manufacturers, and end customers to assemble server systems. It provides server options with single, dual, and quad CPU capability supporting Intel Pentium and Xeon multi-core architectures; and server systems based on AMD dual and quad Opteron. The company also offers server subsystems and accessories, including server boards, and chassis and power supplies. In addition, it sells other system accessories, such as microprocessors, memory, and disc drives. The company sells its server systems, and server subsystems and accessories through distributors, including value added resellers, system integrators, and original equip ment manufacturers, as well as through its direct sales force primarily in the United States, Europe, and Asia. Super Micro Computer, Inc. was founded in 1993 and is headquartered in San Jose, California.
Advisors' Opinion:- [By John Kell var popups = dojo.query(".socialByline .popC"); popups.forEach(func]
Shares of Super Micro Computer Inc.(SMCI) jumped 17% to $22.09 premarket after the servers maker reported better-than-expected profit and sales growth for the fiscal third-quarter. Super Micro also issued a rosy outlook for the fiscal fourth quarter.
- [By Lauren Pollock]
Super Micro Computer Inc.'s(SMCI) fiscal second-quarter profit more than doubled as the servers maker reported a double-digit jump in sales and higher gross margins. The latest results topped Super Micro’s expectations and the company issued a rosy outlook for the fiscal third quarter. Shares surged 12% to�$20.79 premarket.
- [By Jake L'Ecuyer]
Super Micro Computer (NASDAQ: SMCI) shares were also up, gaining 11.50 percent to $21.13 after the company reported upbeat FQ3 results and issued a strong Q4 forecast.
10 Best Quality Stocks For 2014: Global Digital Creations Holdings Ltd (GDC)
Global Digital Creations Holdings Limited is an investment holding company. Through its subsidiaries, the Company operates in three segments: computer graphics (CG) and production segment, which includes CG creation, production and exhibition of motion pictures and production of television series and movies, as well as property rental income; CG training courses segment, engaged in the provision of CG and animation training, and cultural park segment, engaged in the media entertainment and related commercial property development. The Company�� subsidiaries include GDC Holdings Limited, GDC Asset Management Limited, GDC China Limited, GDC Digital Cinema Network Limited, GDC Digital Cinema Network Limited, GDC International Limited and GDC Management Services Limited, among others. On September 6, 2011, it completed the disposal of interests in GDC Technology Limited and GDC Digital Cinema Network Limited. Advisors' Opinion:- [By Barel Karsan]
If you follow Genesis Land (GDC), your head may be spinning by now. It's almost every day now that the current board and the activists trying to take it over are claiming some sort of injustice permeated by the other side. (To watch this battle in real-time, sign up for filing notifications for GDC here.) But surely, behind all the "Our directors are superior to yours" puffery, there are some differences in how each group would run the company differently.
10 Best Quality Stocks For 2014: Entest Biomedical Inc (ENTB)
Entest BioMedical, Inc. (Entest), incorporated on September 24, 2008, is a development-stage company. During the fiscal year ended August 31, 2012, the Company�� business consists of the development and commercialization of immunotherapeutic therapies for the veterinary market, as well as the acquisition and operation of veterinary hospitals. The Company is focusing its research and development efforts toward the development and commercialization of the ImenVax family of canine cancer vaccines. ImenVax I is a therapeutic for canine cancer, which involves isolating tumor cells from the patient and then placing the cells into a cell implant device that is inserted subcutaneously into the patient. ImenVax II, which utilizes cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses.
ImenVax
The Company is conducting a ten dog safety study to Evaluate ImenVax I for the Treatment of Canine Oral Melanoma. As of May 17, 2012 three dogs suffering from oral melanoma have been administered the therapy with no dog suffering any material adverse reaction.
ImenVax II
The Company intends to include adjuvant cytokine along with tumor cells into the implantation device. The adjuvants can be added through cytokine expressing cell line.
ImenVax III
ImenVax III is intended to function by harnessing the ability of placental extracts to combat canine cancers. ImenVax III is intended to treat existing tumors through stimulation of immune responses to kill tumor cells directly; indirectly kill tumor cells by cutting off the tumor blood supply, and block the ability of the tumor to suppress the immune system.
ENT-576
ENT-57 is a therapy being developed by the Company for the treatment of Chronic Obstructive Pulmonary Disease (COPD), such therapy consists of extracting a therapeutic number of cells from a tissue containing in part a stem cell population; processing sai! d population of cells derived from said tissue so as to concentrate said stem cell population; systemic re-administration of said cell population into the same patient, and exposing the patient lung to a sufficient intensity and frequency of laser irradiation necessary to augment therapeutic activity of said cells in said patient suffering from COPD. A therapeutic intervention in COPD would require addressing the issues of inflammation and regeneration.
Advisors' Opinion:- [By Bryan Murphy]
The so-called fundamentals, frankly, don't really matter for Entest BioMedical Inc. (OTCMKTS:ENTB) or Gevo, Inc. (NASDAQ:GEVO). Oh, both GEVO and ENTB are generating sales, but both are consistently taking losses. That's ok though, as for both companies right now, profits aren't really the point - it's the pipeline that matters.
10 Best Quality Stocks For 2014: Jos. A. Bank Clothiers Inc.(JOSB)
Jos. A. Bank Clothiers, Inc. engages in designing, manufacturing, retailing, and direct marketing men?s tailored and casual clothing and accessories in the United States. The company?s product offerings include tuxedos, suits, shirts, vests, ties, sport coats, pants, sportswear, overcoats, sweaters, belts and braces, socks, and underwear. It sells its products primarily under the Jos. A. Bank label through its own and franchised stores, and catalogs, as well as the Internet at josbank.com. The company also sells branded shoes from various vendors. As of April 30, 2011, it operated 515 retail stores, which consists of 489 company-owned full-line stores, 12 company-owned outlet and factory stores, and 14 stores owned and operated by franchisees in 42 states and the District of Columbia. The company was founded in 1905 and is based in Hampstead, Maryland.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
Jos. A Bank Clothiers (NASDAQ: JOSB) shot up 11.19 percent to $56.26 after Men's Wearhouse (NYSE: MW) proposed to acquire Jos. A. Bank for $55 per share in cash. - [By Sue Chang]
After Friday�� closing bell, Jos. A. Bank Clothiers Inc. (JOSB) �said its board rejected rival Men�� Wearhouse�� Inc�� (MW) �sweetened bid to acquire the company for $57.50 a share. The offer is ��nadequate from a financial point of view and not in the best interest of Jos. A. Bank�� stockholders,��the company said in a statement.
10 Best Quality Stocks For 2014: iShares MSCI Japan ETF (EWJ)
iShares MSCI Japan Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Japanese market, as measured by the MSCI Japan Index (the Index). The Index seeks to measure the performance of the Japanese equity market. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. iShares MSCI Japan Index Fund's investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Mark Hulbert]
The ETFs linked to these respective regions that Mr. Nadig�� firm favors are the iShares MSCI Japan fund (EWJ) �, with a 0.53% expense ratio; the iShares MSCI EMU Index fund (EZJ) �, also with a 0.53% expense ratio; and the iShares Core MSCI Emerging Markets fund (IEMG) �, with a 0.18% expense ratio.
- [By Matthew McCall]
iShares MSCI Japan ETF (NYSE: EWJ)
The first country to open for the week after the news out of Ukraine hit the wires was Japan, and it was an ugly open. The major stock indices fell by over two percent before they were able to rebound and the Nikkei finished the first day of the week lower by 1.3 percent. The Japanese Yen was down 0.5 percent versus the U.S. Dollar, which is good news for Japanese exporters.
- [By Richard Shaw]
Securities Mentioned: S&P 500 (SPY), Europe (VGK), Japan (EWJ), China (GXC).
Disclosure: QVM has positions in SPY and VGK as of the creation date of this article (July 11, 2013). We certify that except as cited herein, this is our work product. We received no compensation or other inducement from any party to produce this article, and are not compensated by Seeking Alpha in any way relating to this article.
- [By Philip Springer, President, Retirement Wealth Management, Inc.]
The first of two ETF alternatives here is iShares MSCI Japan (EWJ). It provides broad exposure, with 300 stocks and a tilt toward large export-oriented and financial companies.
10 Best Quality Stocks For 2014: Fusion Pharm Inc (FSPM)
Fusion Pharm, Inc., incorporated on January 21, 1998, manufactures and sells a patent pending commercial hydroponic cultivation system capable of growing almost any herb, vegetable, flower, fruit or terrestrial plant better and faster than traditional farming methods. The Company is the creator and manufacturer of the PharmPods hydroponic cultivation container system. The Company sells and licenses its PharmPods containers to agricultural equipment distributers, urban farming companies and other specialty growers. The Company is focused on the development and commercialization of its patent pending PharmPods cultivation container system. In February 2013, the Company completed the sale of 8 PharmPod High Intensity containers under its licensing agreement with Meadpoint Venture Partners (Meadpoint).
The Company's PharmPods are constructed of standard ISO steel shipping containers that are repurposed for use in hydroponic plant cultivation and are equipped with specialty lighting, irrigation systems, climate-control systems and ventilation for a grow-ready, self-contained agricultural solution. PharmPods allow users to precisely control what a plant receives, grow crops densely, avoid using pesticides, increase yields and automatically water plants.
The Company�� PharmPods are used for agricultural cultivation by urban faming companies and other specialty growers The Company does not own any real estate or other physical properties material to its operations. It operates from leased space.
Advisors' Opinion:- [By Dan Burrows]
From questions regarding the accuracy of publicly-available information about these companies��operations to potential illegal activity, these marijuana stocks have incurred the wrath of federal regulators for good reason:
GrowLife (PHOT) FusionPharm (FSPM) CannaBusiness Group (CBGI) Advanced Cannabis Solutions (CANN) Petrotech Oil and Gas (PTOG) Marijuana Stocks Asking for TroubleBut it doesn’t end there. Investors should run away from all OTC marijuana stocks, including Medical Marijuana (MJNA), Cannabis Science (CBIS), CannaVest (CANV), MediSwipe (MWIP) and GreenGro Technologies (GRNH). As the SEC warns:
No comments:
Post a Comment